North America represents a significant region for acetylcysteine adoption, supported by advanced healthcare systems, rising awareness of respiratory disease management, and increasing access to innovative pharmaceutical treatments. The growing prevalence of chronic respiratory disorders, an aging population, and continuous investments in healthcare infrastructure are...